3 results
8-K
EX-1.1
LIXT
Lixte Biotechnology Holdings Inc
27 Nov 20
Lixte Biotechnology Holdings, Inc. Announces Pricing of $5,700,000 Public Offering; Uplisting to Nasdaq Capital Market and Reverse Stock Split
4:43pm
S-1/A
EX-1.1
LIXT
Lixte Biotechnology Holdings Inc
13 Oct 20
IPO registration (amended)
10:00am
- Prev
- 1
- Next